ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 10

Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88

Keith A. Sikora1, Joshua R. Bennett1, Zuoming Deng2, Wanxia Li Tsai3, April D. Brundidge3, Fatemeh Navid3, Gerlinde Layh-Schmitt3, Eric Hanson4, Massimo G. Gadina5, Louis M. Staudt6, Thomas A. Griffin7 and Robert Colbert3, 1Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Biodata Mining & Discovery, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 5Translational Immunology, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6National Cancer Institute, National Institutes of Health, Bethesda, MD, 7Levine Children’s Hospital at Carolinas Medical Center, Charlotte, NC

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Genetic disorders, innate immunity, juvenile idiopathic arthritis-enthesitis (ERA) and neutrophils

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, May 20, 2017

Session Title: Plenary Abstract Session 3

Session Type: Abstract Submissions

Session Time: 2:30PM-3:00PM

Background/Purpose: Myeloid differentiation primary response 88 (MyD88) is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-κB. Germline loss-of-function mutations in MyD88 cause immunodeficiency, while somatic gain-of-function mutations have been linked to lymphoma. We investigated a child with a progressively destructive small-to-medium joint polyarticular JIA since the age of 2 with persistent neutrophil predominant synovial infiltrates.

Methods: We evaluated the patient and family members by whole exome sequencing (WES), peripheral blood immunophenotyping, and phosphorylated-STAT3 (p-STAT3) quantitation. Functional studies in monocytes and dermal fibroblasts included gene/protein expression, quantitation of neutrophil chemotaxis, and siRNA-mediated knockdown of MyD88 and NF-κB subunit p65 (p65). Wild type (WT) or S222R MyD88-AU1 fusion proteins were re-expressed in MyD88-deficient THP-1 cells. NF-κB activity in THP-1 cells was measured via p65 phosphorylation. Molecular mechanistic studies assessing capacity of S222R MyD88 to aggregate, which is necessary for pathway signaling, were performed via centrifugal sedimentation and immunofluorescence imaging.

Results:  WES revealed a de novo heterozygous missense mutation in MYD88 (c.666T>G, p.Ser222Arg), which was confirmed by Sanger sequencing in both peripheral leukocytes and dermal fibroblasts. Immunophenotyping showed a persistent absence of CD16+ monocytes, an expansion of CD4+ Th17 T cells, and the presence of a previously uncharacterized CD123+CD11c+ dendritic cell population, as well as markedly increased basal and stimulated p-STAT3 in monocytes and T and B lymphocytes in the patient. Peripheral monocytes exhibited a baseline interferon gene expression signature and increased expression of neutrophil and monocyte chemokines. Fibroblasts exhibited significantly greater baseline expression of CXCL chemokines compared to controls, which abated upon MyD88 or p65 knockdown. Re-expression of WT or S222R MyD88-AU1 fusion protein in MyD88-knockout THP-1 cells demonstrated increased p65 phosphorylation in S222R-MyD88-expressing cells compared to WT. Similar to L265P, the most common lymphoma-associated MyD88 gain-of-function somatic mutation, S222R-MyD88 aggregated in THP-1 cells to a greater extent than WT MyD88 protein, which was visualized by immunoblotting of re-solubilized aggregates as well as immunofluorescence microscopy.

Conclusion:  This is the first description of a de novo germline MyD88 mutation associated with severe polyarticular JIA. Gain-of-function effects demonstrated in the patient’s hematopoietic and non-hematopoietic cells, occurring through increased MyD88-S222R aggregation, offer a plausible mechanism for arthritis and support a role for single gene defects contributing to extreme JIA phenotypes.


Disclosure: K. A. Sikora, None; J. R. Bennett, None; Z. Deng, None; W. L. Tsai, None; A. D. Brundidge, None; F. Navid, None; G. Layh-Schmitt, None; E. Hanson, None; M. G. Gadina, None; L. M. Staudt, None; T. A. Griffin, None; R. Colbert, None.

To cite this abstract in AMA style:

Sikora KA, Bennett JR, Deng Z, Tsai WL, Brundidge AD, Navid F, Layh-Schmitt G, Hanson E, Gadina MG, Staudt LM, Griffin TA, Colbert R. Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88 [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/severe-juvenile-arthritis-associated-with-a-de-novo-gain-of-function-germline-mutation-in-myd88-2/. Accessed January 31, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/severe-juvenile-arthritis-associated-with-a-de-novo-gain-of-function-germline-mutation-in-myd88-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences